胰腺分支胰管型 IPMN 的癌症预后。

Prognosis of cancer with branch duct type IPMN of the pancreas.

机构信息

Department of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjyuku, Shinjyuku-ku, Tokyo 160-0023, Japan.

出版信息

World J Gastroenterol. 2010 Apr 21;16(15):1890-5. doi: 10.3748/wjg.v16.i15.1890.

DOI:10.3748/wjg.v16.i15.1890

PMID:20397268

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2856831/

Abstract

AIM

To examine the coexistence of metachronous and synchronous cancer in branch duct intraductal papillary mucinous neoplasms of the pancreas (IPMN).

METHODS

We reviewed the records of 145 patients with branch duct IPMN between January 1991 and April 2008 and assessed the relationship between IPMN and intra- or extra-pancreatic carcinoma and the outcome of IPMN.

RESULTS

The mean observation period was 55.9 +/- 45.3 mo. Among the 145 patients, the frequency of extra-pancreatic cancer was 29.0%. The frequency of gastric cancer, colon cancer, breast cancer, and pancreatic cancer were 25.5%, 15.7%, 13.7%, and 9.8%, respectively. Twenty (13.8%) of the patients died. The cause of death was extra-pancreatic carcinoma in 40%, pancreatic cancer in 25%, IPMN per se in 20%, and benign disease in 15% of the patients.

CONCLUSION

The prognosis for IPMN depends not on the IPMN per se, but on the presence of intra- or extra-pancreatic cancer.

摘要

目的

探讨胰腺分支导管内乳头状黏液性肿瘤（IPMN）中同时性和异时性癌症的共存情况。

方法

我们回顾了 1991 年 1 月至 2008 年 4 月期间 145 例分支导管 IPMN 患者的记录，并评估了 IPMN 与胰内或胰外癌之间的关系以及 IPMN 的转归。

结果

平均观察期为 55.9 +/- 45.3 个月。在 145 例患者中，胰外癌的发生率为 29.0%。胃癌、结肠癌、乳腺癌和胰腺癌的发生率分别为 25.5%、15.7%、13.7%和 9.8%。20 例（13.8%）患者死亡。死亡原因分别为胰外癌 40%、胰腺癌 25%、IPMN 本身 20%和良性疾病 15%。

结论

IPMN 的预后不仅取决于 IPMN 本身，还取决于胰内或胰外癌的存在。

相似文献

Prognosis of cancer with branch duct type IPMN of the pancreas.

World J Gastroenterol. 2010 Apr 21;16(15):1890-5. doi: 10.3748/wjg.v16.i15.1890.

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.

Gut. 2008 Nov;57(11):1561-5. doi: 10.1136/gut.2007.145631. Epub 2008 May 13.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9. doi: 10.1097/01.sla.0000128306.90650.aa.

Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm.

World J Gastroenterol. 2009 Nov 21;15(43):5489-92. doi: 10.3748/wjg.15.5489.

Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.

J Clin Gastroenterol. 2006 Oct;40(9):856-62. doi: 10.1097/01.mcg.0000225609.63975.6f.

Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas.

J Gastroenterol. 2010 Sep;45(9):952-9. doi: 10.1007/s00535-010-0238-0. Epub 2010 Apr 10.

Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.

Endoscopy. 2010 Dec;42(12):1077-84. doi: 10.1055/s-0030-1255971. Epub 2010 Nov 30.

Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.

J Gastroenterol Hepatol. 2009 Jul;24(7):1211-7. doi: 10.1111/j.1440-1746.2009.05826.x. Epub 2009 May 19.

Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.

Eur J Surg Oncol. 2016 Feb;42(2):197-204. doi: 10.1016/j.ejso.2015.10.014. Epub 2015 Dec 1.

Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.

Surgery. 2015 Oct;158(4):937-44; discussion 944-5. doi: 10.1016/j.surg.2015.06.003. Epub 2015 Jul 11.

引用本文的文献

Subtype of intraductal papillary mucinous neoplasm of the pancreas is important to the development of metachronous high-risk lesions after pancreatectomy.

Ann Hepatobiliary Pancreat Surg. 2019 Nov;23(4):365-371. doi: 10.14701/ahbps.2019.23.4.365. Epub 2019 Nov 29.

Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.

Medicine (Baltimore). 2019 Nov;98(47):e18039. doi: 10.1097/MD.0000000000018039.

Early diagnosis of pancreatic cancer: Current trends and concerns.

Ann Gastroenterol Surg. 2017 Apr 25;1(1):44-51. doi: 10.1002/ags3.12004. eCollection 2017 Apr.

Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions.

Endosc Ultrasound. 2016 Nov-Dec;5(6):377-383. doi: 10.4103/2303-9027.190927.

Endoscopic approach to the diagnosis of pancreatic cystic tumor.

World J Gastrointest Oncol. 2016 Feb 15;8(2):159-64. doi: 10.4251/wjgo.v8.i2.159.

International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Ann Transl Med. 2015 Nov;3(19):286. doi: 10.3978/j.issn.2305-5839.2015.11.09.

Metachronous double cancer after curative resection for pancreatic adenocarcinoma: report of four cases.

Clin J Gastroenterol. 2012 Apr;5(2):108-12. doi: 10.1007/s12328-011-0280-3. Epub 2011 Dec 28.

Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature.

World J Gastroenterol. 2015 Jun 21;21(23):7313-9. doi: 10.3748/wjg.v21.i23.7313.

Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas.

Dig Endosc. 2015 May;27(4):450-457. doi: 10.1111/den.12434. Epub 2015 Feb 5.

Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.

World J Gastroenterol. 2013 Mar 7;19(9):1451-7. doi: 10.3748/wjg.v19.i9.1451.

本文引用的文献

Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.

Pancreatology. 2008;8(6):577-82. doi: 10.1159/000159844. Epub 2008 Sep 29.

Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.

Ann Surg Oncol. 2008 Nov;15(11):3193-8. doi: 10.1245/s10434-008-0143-4. Epub 2008 Sep 11.

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.

Gut. 2008 Nov;57(11):1561-5. doi: 10.1136/gut.2007.145631. Epub 2008 May 13.

Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):807-14. doi: 10.1016/j.cgh.2007.12.021. Epub 2008 Mar 4.

Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.

Clin Gastroenterol Hepatol. 2006 Oct;4(10):1265-70. doi: 10.1016/j.cgh.2006.07.013. Epub 2006 Sep 18.

Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.

Surgery. 2006 Jun;139(6):749-54. doi: 10.1016/j.surg.2005.11.008.

High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.

Arch Surg. 2006 Jan;141(1):51-6; discussion 56. doi: 10.1001/archsurg.141.1.51.

Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas.

World J Surg. 2005 Dec;29(12):1650-7. doi: 10.1007/s00268-005-0035-8.

Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas.

World J Gastroenterol. 2005 Sep 28;11(36):5688-90. doi: 10.3748/wjg.v11.i36.5688.

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

Ann Surg. 2004 May;239(5):678-85; discussion 685-7. doi: 10.1097/01.sla.0000124386.54496.15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

胰腺分支胰管型 IPMN 的癌症预后。

Prognosis of cancer with branch duct type IPMN of the pancreas.

机构信息

Department of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjyuku, Shinjyuku-ku, Tokyo 160-0023, Japan.

出版信息

World J Gastroenterol. 2010 Apr 21;16(15):1890-5. doi: 10.3748/wjg.v16.i15.1890.

DOI:10.3748/wjg.v16.i15.1890

PMID:20397268

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2856831/

Abstract

AIM

To examine the coexistence of metachronous and synchronous cancer in branch duct intraductal papillary mucinous neoplasms of the pancreas (IPMN).

METHODS

RESULTS

CONCLUSION

The prognosis for IPMN depends not on the IPMN per se, but on the presence of intra- or extra-pancreatic cancer.

摘要

目的

探讨胰腺分支导管内乳头状黏液性肿瘤（IPMN）中同时性和异时性癌症的共存情况。

方法

我们回顾了 1991 年 1 月至 2008 年 4 月期间 145 例分支导管 IPMN 患者的记录，并评估了 IPMN 与胰内或胰外癌之间的关系以及 IPMN 的转归。

结果

结论

IPMN 的预后不仅取决于 IPMN 本身，还取决于胰内或胰外癌的存在。

胰腺分支胰管型 IPMN 的癌症预后。

Prognosis of cancer with branch duct type IPMN of the pancreas.

机构信息

出版信息

AIM

METHODS

RESULTS

CONCLUSION

目的

方法

结果

结论

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

胰腺分支胰管型 IPMN 的癌症预后。

Prognosis of cancer with branch duct type IPMN of the pancreas.

机构信息

出版信息

AIM

METHODS

RESULTS

CONCLUSION

目的

方法

结果

结论